Two proteins identified as potential targets to improve ALS symptoms

Estimated reading time: 1 minutes

• About The Author

Scientists have found that the protein histone H1.2 and the enzyme PARP1 could be potential therapeutic targets to decrease neurodegeneration in amyotrophic lateral sclerosis (ALS).

About The Author

See author's posts

Trending

The Ultimate Guide to Instagram Influencer Marketing for Brands